This week the FDA approved a new flu vaccine targeting adults 50 and older.
The idea is that if a new strain becomes dominant right before flu season, this vaccine would offer better protection.
For a closer look, KCBS News Anchor Peter Finch spoke with Dr. Peter Chin-Hong, UCSF infectious disease specialist.
Getty Images / Joe Raedle
